Humana Inc. HUM
NYSE · Healthcare · Medical - Healthcare Plans
$389.91
Close on Fri, 20 Nov 2026 · market value $46.8B
What the price is betting on
In line with its recordAt $390, the price assumes revenue grows about 11% a year for five years, from $154B to about $236B by FY2030. That is about the same as what analysts expect for the next two years and less than the company's own last three years.
Revenue growth a year. The price figure comes from a reverse DCF at a 8.1% discount rate.
Track it and Parra checks each report against the path, and tells you when revenue falls behind it.
Own more than HUM? Check up to 5 of your stocks at once, free, no account.
Both sides
Three stories, three values
Bear
$343
Base
$373
Bull
$410
Today $390
- Bear $343. Cash flow grows 5% a year for the next 5 years, slower than expected, then slows to long-run growth.
- Base $373. Cash flow grows 9% a year for the next 5 years, as analysts expect, then slows to long-run growth.
- Bull $410. Cash flow grows 12% a year for the next 5 years, faster than expected, then slows to long-run growth.
Stories set by rules from the company’s record.
Checkpoints
The revenue the price needs
- YearNeedsAnalysts expect
- FY2026$158B$163B, on the path
- FY2027$175B$174B, on the path
- FY2028$193B$190B, on the path
- FY2029$214B$202B, below the path
- FY2030$236B$213B, below the path
Each year's revenue at 11% growth from $154B in the 12 months to September 2026.
At a glance
Healthcare · Medical - Healthcare Plans · listed on NYSE
- Revenue, FY2025
- $130B
- Growth, 3 years a year
- 14%
- Cash margin
- 0.3%
- Net debt
- $8.7B
- Shares, 3-year change
- −4.9%
- Dividend yield
- 0.9%
What other healthcare prices are betting on
Figures from company filings and end-of-day market data, as of the close on Fri, 20 Nov 2026; updated every trading day. This page shows what today's price assumes, not whether to buy or sell. Not investment advice.